正瀚生技股份有限公司 Approved
最後更新時間 2025/07/11 , 04:28 AM
最後更新時間 2025/07/11 , 04:28 AM
負責人
Wu,Zheng-Bang
統一編號
54313303
成立日期
2013/11/29
資本額
NT$1,500,000,000
實收資本額
NT$1,028,000,000
股票代號
6534
電話
049-7009198
地址
No. 89, Wunsian Rd., Nantou City, Nantou County, 540, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Wu,Zheng-Bang Chairman 2.88%
Wu,Cheng-Han Director 0.16%
ZHAO SONG INVESTMENT LTD. Director 16.73%
WEALTH MILESTONE INVESTMENT CORP. Director 4.69%
AO SHI YING INVESTMENT CO., LTD. Director 1.41%
LOVELAND PRODUCTS CANADA INC. Director 22.49%
Qiu,Yong-Xiang Independent Director 0.00%
Liu,Wan-Yu Independent Director 0.00%
Zhou,Yin-Xiang Independent Director 0.00%
營業項目
  • Manufacture of Fertilizers and Nitrogen Compounds(183099)
  • Manufacture of Pesticides and Environmental Agents(191011)
  • Wholesale of Non-alcoholic Beverages(454700)
  • Wholesale of Coffee, Tea and Spices(454811)
  • 公司歷程
  • Change Capital to 1,500,000,000
    2021/07/15
  • Change Capital to 1,000,000,000
    2019/06/05
  • Change Capital to 800,000,000
    2017/10/11
  • Change Capital to 400,000,000
    2014/11/14
  • Change Capital to 6,000,000
    2014/01/03
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 853,655 1,635,736 1,514,829
    Operating cost 113,007 270,919 254,733
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 740,648 1,364,817 1,260,096
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 740,648 1,364,817 1,260,096
    Operating expenses 250,286 822,522 694,236
    Other gain (loss), net - - -
    Operating profit (loss) 490,362 542,295 565,860
    Non-operating income and expenses 8,542 50,667 13,074
    Net profit (loss) before tax 498,904 592,962 578,934
    Income tax expense (benefits) 99,600 117,272 115,643
    Net profit (loss) of ongoing business for the current period 399,304 475,690 463,291
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 399,304 475,690 463,291
    Other comprehensive profit (loss), net 4,280 17,777 -554
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 403,584 493,467 462,737
    Net profit (loss) attributable to owners of parent company 399,395 476,386 463,291
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -91 -696 -
    Comprehensive profit (loss) attributable to owners of parent company 403,675 494,163 462,737
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -91 -696 -
    Basic earnings per share (yuan) 3 4 4
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 208,722 538,443 659,154
    Net cash inflows (outflows) from investing activities -42,490 -594,767 -142,893
    Net cash inflow (outflow) from financing activities 11,661 -406,211 -106,600
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 701 1,460 245
    Increase (decrease) in cash and cash equivalents in the current period 178,594 -461,075 409,906
    Beginning balance of cash and cash equivalents 478,855 939,930 530,024
    Ending balance of cash and cash equivalents 657,449 478,855 939,930
    項目 2025 2024 2023
    Current asset 1,348,018 852,593 1,235,428
    Non-current asset 2,767,364 2,776,590 2,413,782
    Total asset 4,115,382 3,629,183 3,649,210
    Current liability 1,149,743 646,930 882,324
    Non-current liability 285,390 335,508 246,738
    Total liability 1,435,133 982,438 1,129,062
    share capital 1,028,000 1,028,000 1,028,000
    Equity - secruity token - - -
    capital reserve 718,260 718,260 717,644
    retained earning 906,508 877,193 771,204
    Other equity 26,702 22,422 3,300
    Treasury stock - - -
    Total equity attributable to owners of parent company 2,679,470 2,645,875 2,520,148
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 779 870 -
    Total Equity 2,680,249 2,646,745 2,520,148
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 26 25 24
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 富肽
  • CH BIOTECH
  • 標章圖
  • COFFEELAND
  • 羊圖形
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Others
    2018
  • Pay for the project
    2020, 2022
  • Pay construction fees, etc.
    2020, 2023, 2024
  • Tobacco and Alcohol Management Act
    2017
  • Ruling of legal expenses ex officio
    2020
  • Payment order
    2020
  • Pay for the project
    2021, 2023
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。